Shuichiro Matoba

Toranomon Hospital

Papers

3

Total Citations

39

H-Index

3

About

Shuichiro Matoba is a leading colorectal surgeon whose research focuses on advancing minimally invasive surgical techniques for rectal cancer, particularly in locally advanced cases. His major contributions center on validating the safety and efficacy of laparoscopic and robotic-assisted surgery through rigorous prospective multicenter trials. Notably, he led the PRODUCT trial, a Japanese multicenter study that established a novel semi-opened circular specimen processing method to evaluate circumferential resection margin (CRM) and total mesorectal excision (TME) quality—critical benchmarks for oncological outcomes. This work, cited 19 times, provides essential evidence supporting laparoscopic approaches in advanced rectal cancer. Matoba also spearheaded the VITRUBIANO trial, a phase II study demonstrating the feasibility of robotic-assisted surgery with strict surgeon criteria, earning 17 citations. His 2018 review on laparoscopic treatment and lateral pelvic lymph node dissection challenges the obsolescence of these techniques, arguing for their continued relevance with proper training. With cumulative citations reflecting growing influence, Matoba’s work bridges surgical innovation and rigorous clinical validation, offering students and researchers a model for evidence-based advancement in colorectal oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
39
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Japanese multicenter prospective study investigating laparoscopic surgery for locally advanced rectal cancer with evaluation of CRM and TME quality (PRODUCT trial)
19 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: Toranomon Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago